Do citric acid and isocitric acid accumulate when mitochondrial dysfunction is elevated?

Elevated levels of the early tricarboxylic acid (TCA) cycle intermediates, citric acid and isocitric acid, in the presence of mitochondrial dysfunction represent a key metabolic signature. Rather than indicating robust energy production, this accumulation reflects a significant bottleneck in mitochondrial respiration.

Mechanisms of TCA cycle bottlenecks

• Isocitrate dehydrogenase (IDH) block: IDH catalyzes the rate-limiting conversion of isocitrate to $\alpha$-ketoglutarate. Impairment of this enzyme under mitochondrial stress restricts forward oxidative flux, causing a rapid, mass-action accumulation of upstream isocitric acid.
• Aconitase (ACO2) impairment: Mitochondrial aconitase is highly susceptible to oxidative stress and iron dysregulation. Structural or functional impairment of ACO2 halts downstream citrate catabolism, leading to a marked accumulation of intracellular citrate.
• Equilibrium back-propagation: Because the interconversion of citrate and isocitrate is a near-equilibrium reaction, a bottleneck at either IDH or ACO2 propagates backward. This biochemical coupling causes a simultaneous, parallel accumulation of both early intermediates.
• Redox and enzymatic inhibition: Systemic mitochondrial dysfunction and an elevated NADH/NAD+ ratio further drive these enzymatic blocks, trapping carbon in the early phases of the cycle instead of allowing smooth downstream oxidation.

Bottom line

• The accumulation of citric and isocitric acid alongside elevated mitochondrial dysfunction markers indicates an uneven, bottlenecked TCA cycle. This metabolic profile signifies compromised downstream oxidative flux—typically driven by IDH or ACO2 impairment—rather than efficient energy production.